News
- Ibogaine
- Ketamine
- LSD
- MDMA
- Psilocybin
Resources
Multimedia
Events
About Us

Ketamine

FDA Approves IND Application for Freedom’s Ketamine-Based Combination Therapy

April 26, 2024

NRx Says New Formulation of IV Ketamine Could Be Delivered Subcutaneously

April 15, 2024

NRx Pharmaceuticals Achieves Data Lock in Phase 2B/3 Trial of NRX-101

April 10, 2024

MIRA Pharmaceuticals Shares Encouraging Pre-Clinical Results for Ketamir-2

April 2, 2024

Itzchak Angel Joins MIRA Pharmaceuticals as Chief Scientific Advisor

March 22, 2024

At-Home Ketamine Therapy: Breakthrough or Breakdown?

March 21, 2024

Silo Pharma Files Patent for Ketamine-Implant Therapeutic

March 18, 2024

ATMA CENA Psychedelic Healthcare Solutions Begins Operations at Calgary Clinic

March 16, 2024

Home
News
Multimedia
Resources
Opinion
Events
About Us

Contact Us

Name *

Email *

Subject *

Message